NCT06806410

Brief Summary

Patients undergoing hand, wrist, and elbow surgery may experience pain after surgery. The orthopedic surgeon may provide prescription pain medications after surgery to assist with pain control. However, with concern of the opioid epidemic, many patients would rather minimize the use of narcotic pain prescriptions after having surgery. As an alternative, ultrasound guided regional nerve blocks can assist with postoperative pain control. patients consented to this study will be randomized into three groups: 1) will receive an ultrasound guided nerve block with local anesthesia only, 2) will receive an ultrasound guided nerve block with local anesthesia and a steroid dexamethasone, 3) will receive an ultrasound guided nerve block with liposomal bupivacaine. our study team will make phone calls after surgery to the patient to determine how long the block lasted for, and how many opioid pain pills were taken up to 3 days after surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 4, 2025

Completed
Last Updated

February 6, 2025

Status Verified

January 1, 2025

Enrollment Period

1.6 years

First QC Date

January 28, 2025

Last Update Submit

February 3, 2025

Conditions

Keywords

liposomal bupivacainesupraclavicular nerve blockultrasound guided nerve blockhand, wrist, elbow surgerylocal anestheticdexamethasone perineural injection

Outcome Measures

Primary Outcomes (1)

  • Subjective length of duration of block

    our study team contacts the patients 4 days after surgery to ask how long their regional nerve block lasted

    feedback obtained up until day 3 after surgery

Secondary Outcomes (1)

  • Number of opioid pills taken until postoperative day 3

    feedback until day 3 after surgery

Study Arms (3)

Control Arm: local anesthesia only in ultrasound guided supraclavicular nerve block

NO INTERVENTION

ultrasound guided supraclavicular nerve blocks are typically performed with the use of local anesthesia only

Study Arm: local anesthesia with perineural dexamethasone

EXPERIMENTAL

dexamethasone is a potent steroid that when provided in ultrasound guided nerve blocks can extend the duration of the nerve block.

Drug: Dexamethasone

Study Arm: liposomal bupivacaine

EXPERIMENTAL

our study team would like to determine how use of liposomal bupivacaine in supraclavicular nerve blocks can lengthen the duration of the nerve block, and how it may affect the number of opioid pills used after surgery up until postoperative day three.

Drug: Liposomal bupivacaine (LB)

Interventions

our study team wishes to determine effect of liposomal bupivacaine in regional nerve blocks for surgery of the upper extremity (finger, hand, wrist, elbow)

Also known as: liposomal bupivacaine, exparel
Study Arm: liposomal bupivacaine

dexamethasone injected in perineural area can extend the regional nerve block

Also known as: decadron perineural injection
Study Arm: local anesthesia with perineural dexamethasone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients scheduled to undergo finger, hand, wrist, elbow surgery with a hand surgeon at St. Luke's University Hospital in Bethlehem, Pennsylvania
  • patients greater than 18 years of age, able to provide written consent for surgery and study

You may not qualify if:

  • patients that cannot provide written consent for finger, hand, wrist, elbow surgery
  • patients with known allergies to local anesthetics
  • patients with severe liver disease
  • patients with a condition known as methemoglobinemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Luke's University Health Network

Bethlehem, Pennsylvania, 18015, United States

Location

MeSH Terms

Conditions

Dupuytren ContractureWrist Fractures

Interventions

Dexamethasone

Condition Hierarchy (Ancestors)

FibromaNeoplasms, Fibrous TissueNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsContractureMuscular DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesWrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Officials

  • Anna Ng-Pellegrino, MD

    St. Luke's Hospital and Health Network, Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
the patient is blinded to the study arm
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomization into three groups. Control group is administration of local anesthesia in ultrasound guided supraclavicular nerve blocks. There are two study groups. The intermediate study group is administration of local anesthesia with dexamethasone in the ultrasound guided supraclavicular nerve block. The other study group is administration of liposomal bupivacaine in the ultrasound guided supraclavicular nerve block.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 4, 2025

Study Start

May 1, 2023

Primary Completion

November 30, 2024

Study Completion

January 30, 2025

Last Updated

February 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

we will provide results on our measured outcomes: subjective length of duration of block, number of opioid pills taken by postsurgical day 3. we will provide de-identified information on demographics as well between the control arm and treatment arms

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
we will provide deidentified data on patients participating within the start to end dates of patient recruitment. This data will be available to view in anticipated publication to a journal
Access Criteria
This information can be available to view after publication to a journal.

Locations